Recombinant Saccharomyces cerevisiae U6 snRNA-associated Sm-like protein LSm6 (LSM6)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Saccharomyces cerevisiae U6 snRNA-associated Sm-like protein LSm6 (LSM6)

LSM6 is a member of the Sm-like (LSm) protein family, characterized by a conserved β-sheet structure and RNA-binding capability. It is integral to the U6 small nuclear ribonucleoprotein (snRNP) complex, critical for pre-mRNA splicing in eukaryotes . Recombinant LSM6 is produced in various expression systems, including Saccharomyces cerevisiae, E. coli, baculovirus, and mammalian cells, with applications in RNA processing studies and biotechnology .

Production Methods and Recombinant Expression

Recombinant LSM6 is synthesized using diverse systems:

Expression SystemSource OrganismKey FeaturesCitations
YeastS. cerevisiaeNative production, high purity
E. coliBL21(DE3)AviTag-biotinylated (via BirA)
BaculovirusInsect cellsPost-translational modifications
MammalianHEK293/CHOHigh-yield expression

Proteomic studies reveal that E. coli M15 strains exhibit superior recombinant protein expression efficiency compared to DH5α, with optimal induction at mid-log phase (OD600 ~0.6) .

Biological Functions in RNA Metabolism

LSM6 participates in two primary pathways:

4.1. Nuclear Role: Pre-mRNA Splicing

  • U6 snRNA Stabilization: The Lsm2–8 complex chaperones U6 snRNA, ensuring its proper folding and integration into the spliceosome .

  • Spliceosome Dynamics: Facilitates U4/U6 snRNP reassociation after intron excision, enabling spliceosome recycling .

4.2. Cytoplasmic Role: mRNA Decay

  • Decapping Activation: Interacts with Pat1 and Dcp1/Dcp2 complexes to initiate 5′-to-3′ mRNA degradation .

  • P-Body Localization: Associates with processing bodies (P-bodies) to regulate mRNA stability .

Applications in Research and Biotechnology

  • RNA Processing Studies: Used to investigate spliceosome assembly and mRNA turnover .

  • Therapeutic Targets: Potential applications in modulating gene expression for cancer or neurodegenerative diseases .

  • Commercial Availability: Recombinant LSM6 is marketed for structural biology and biochemical assays .

Future Research Directions

  • Structural Elucidation: High-resolution crystallography to map LSm6-RNA interactions .

  • Therapeutic Engineering: Engineering LSM6 variants to modulate RNA processing in disease models .

  • Systems Biology: Integrating proteomic data to optimize recombinant production .

Product Specs

Form
Lyophilized powder. Note: We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times may vary based on purchasing method and location. Consult your local distributor for specific delivery information. Note: All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize developing it.
Synonyms
LSM6; SCY_1265U6 snRNA-associated Sm-like protein LSm6
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-86
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Saccharomyces cerevisiae (strain YJM789) (Baker's yeast)
Target Names
LSM6
Target Protein Sequence
MSGKASTEGS VTTEFLSDII GKTVNVKLAS GLLYSGRLES IDGFMNVALS SATEHYESNN NKLLNKFNSD VFLRGTQVMY ISEQKI
Uniprot No.

Target Background

Function
LSM6 is a component of LSm protein complexes involved in RNA processing, possibly acting as a chaperone to facilitate the interaction of RNA processing factors with their substrates. It is part of the cytoplasmic LSM1-LSM7 complex, involved in mRNA degradation by activating decapping in the 5'-to-3' mRNA decay pathway. With PAT1, LSM1-LSM7 binds directly to RNAs near the 3'-end, preferring oligoadenylated over polyadenylated RNAs. LSM6 is also a component of the nuclear LSM2-LSM8 complex, involved in splicing nuclear mRNAs. LSM2-LSM8 associates with multiple snRNP complexes containing U6 snRNA (U4/U6 di-snRNP, U4/U6.U5 tri-snRNP, and free U6 snRNP). It binds to the 3'-terminal U-tract of U6 snRNA and contributes to the biogenesis and stability of U6 snRNP and U4/U6 snRNP complexes. LSM2-LSM8 is likely involved in nuclear pre-mRNA degradation via decapping and in processing pre-tRNAs, pre-rRNAs, and U3 snoRNA. Finally, LSM6 is part of a nucleolar LSM2-LSM7 complex that associates with pre-P RNA (precursor of RNase P RNA) and snR5 snoRNA, potentially playing a role in the maturation of certain nucleolus-associated small RNAs.
Protein Families
SnRNP Sm proteins family, SmF/LSm6 subfamily
Subcellular Location
Cytoplasm. Nucleus, nucleolus.

Q&A

What is LSM6 and what is its role in Saccharomyces cerevisiae?

LSM6 is a U6 snRNA-associated Sm-like protein encoded by the LSM6 gene. It belongs to the Sm-like protein family that was identified based on sequence homology with the Sm protein family . In yeast, LSM6 is involved in RNA processing, particularly pre-mRNA splicing, as part of a complex of Sm-like proteins that associate with U6 snRNA . Additionally, when overexpressed, LSM6 has been shown to enhance yeast tolerance to various inhibitors present in biomass hydrolysates, suggesting a role in stress response mechanisms .

What is the structural organization of LSM6?

LSM6 contains the characteristic Sm sequence motif, which consists of two regions separated by a linker of variable length that folds as a loop . This structural motif is conserved across Sm and Sm-like proteins. LSM6 does not function individually but forms part of a complex with other LSM proteins. Specifically, the LSM6 protein is part of a seven-subunit complex, with co-precipitation experiments demonstrating that LSM2-7 proteins can associate with the LSM8 protein . The complex likely contains a single copy of each monomer, forming a structure with seven repeats of the basic unit .

What vectors and transformation approaches are optimal for LSM6 overexpression in yeast?

For successful overexpression of LSM6 in S. cerevisiae, the expression vector pRS426 has been demonstrated to be effective . This is a high-copy number yeast shuttle vector containing a selection marker that allows for identification of transformants. When designing an experiment, consider:

  • The transformation protocol (lithium acetate method is commonly used for yeast)

  • Selection strategy (positive transformants can be initially identified on culture plates with high acetate concentration)

  • Verification method (PCR, Western blotting)

  • Secondary screening (fermentation tests to confirm phenotype)

In the study by Gao and Xia, the positive transformant with overexpressing LSM6 (designated ZU-910) was identified on culture plates using high concentration of acetate and then re-screened by fermentation test to confirm enhanced inhibitor tolerance .

How can researchers quantify the effects of LSM6 overexpression on inhibitor tolerance?

To properly quantify the effects of LSM6 overexpression on inhibitor tolerance, researchers should implement a multi-faceted approach:

  • Growth curve analysis in media containing different inhibitors (acetic acid, furfural, SO4(2-))

  • Fermentation performance metrics:

    ParameterControl (ZU-E8)LSM6 Overexpression (ZU-910)Improvement
    Xylose utilization (%)Low90.2%Significant
    Ethanol yield (g/L)~2.726.98.5-10 fold
    Inhibitor toleranceBase levelEnhancedVariable
    Corn stover hydrolysate xylose conversionBase level50% higherSignificant
    Corn stover hydrolysate ethanol productionBase level40% higherSignificant
  • Cell viability assays after exposure to different inhibitors

  • Testing in actual hemicellulosic hydrolysates to assess performance under industrial conditions

Statistical analysis should include appropriate controls and biological replicates, with results reported as mean values with standard deviations.

What controls and variables should be considered when studying LSM6 complex formation?

When designing experiments to study LSM6 complex formation, researchers should consider:

  • Genetic background effects: Use isogenic strains differing only in the gene of interest

  • Environmental factors: Control temperature, growth phase, and media composition

  • Detection methods for protein-protein interactions:

    • Co-immunoprecipitation (successfully used to show LSM2-7 proteins associate with LSM8)

    • Two-hybrid assays (with caution, as search result notes these require validation)

    • Structural studies

  • Important controls:

    • Negative controls (non-specific antibodies, unrelated proteins)

    • Positive controls (known interacting partners)

    • Empty vector controls

  • RNA association analysis: As noted in search result , nearly all U6 snRNA associates with the LSM3 protein in a cell expressing LSM3-ProtA fusion, suggesting that different LSM proteins are not associated with different subpools of U6 snRNA .

How do mutations in the Sm domain of LSM6 affect its function?

To investigate how mutations in the Sm domain affect LSM6 function, researchers should implement:

  • Structure-guided mutagenesis targeting:

    • Conserved residues in the Sm motif regions

    • The variable linker region between the two Sm motif segments

    • Putative RNA-binding sites

    • Regions involved in protein-protein interactions

  • Functional assays to assess mutant phenotypes:

    • Growth at different temperatures (30°C and 37°C, since LSM6 disruption causes temperature-sensitive growth)

    • Inhibitor tolerance tests (particularly with acetic acid)

    • RNA processing efficiency measurements

    • Complex formation analysis (co-immunoprecipitation with other LSM proteins)

  • RNA binding analysis using techniques such as:

    • RNA immunoprecipitation followed by RT-PCR or sequencing

    • Electrophoretic mobility shift assays

    • UV crosslinking experiments

Results should be analyzed in the context of LSM6's dual roles in RNA processing and stress tolerance.

What experimental approaches can differentiate between direct and indirect effects of LSM6 on stress tolerance?

Distinguishing between direct and indirect effects of LSM6 on stress tolerance requires:

  • Temporal analysis of gene expression and metabolic changes following stress exposure in wild-type vs. LSM6-overexpressing strains

  • Direct binding studies:

    • Identify whether LSM6 directly interacts with stress response factors

    • Determine if LSM6's RNA processing function is altered under stress conditions

  • Genetic interaction mapping:

    • Use synthetic genetic arrays to identify genes that interact with LSM6

    • Employ epistasis analysis with known stress response genes

  • Domain-specific mutations:

    • Create mutants that separate RNA processing function from stress tolerance

    • Test whether one function can exist without the other

  • Metabolic flux analysis:

    • Measure changes in central carbon metabolism

    • Determine if LSM6 affects energy generation or redirection under stress

The enhanced inhibitor tolerance seen in LSM6-overexpressing strains (like ZU-910) with significantly improved fermentation performance in the presence of inhibitors could result from either direct effects on inhibitor metabolism or indirect effects through altered RNA processing of stress response genes.

How can researchers study LSM6's role in complex formation with other LSM proteins?

To study LSM6's role in complex formation with other LSM proteins, researchers should consider:

  • Protein tagging strategies:

    • Epitope tagging of LSM6 and potential partners

    • Fluorescent protein fusions for localization studies

  • Affinity purification approaches:

    • Tandem affinity purification to isolate intact complexes

    • Mass spectrometry analysis of complex components

  • Structural biology techniques:

    • Cryo-EM for structural determination of complexes (as used for other yeast complexes in )

    • Cross-linking mass spectrometry to identify interaction interfaces

  • In vitro reconstitution:

    • Purify individual components and reconstitute complexes

    • Test the effect of mutations on complex assembly

  • RNA association analysis:

    • Determine whether complex formation is RNA-dependent

    • Identify the RNA species associated with different complexes

The data from search result indicates that the LSM2-7 proteins can associate with LSM8 proteins and that there is likely a single copy of each monomer per complex, similar to the canonical Sm complex .

How can contradictions in LSM6 function between different studies be reconciled?

When encountering contradictory data regarding LSM6 function, researchers should systematically analyze:

  • Strain background differences:

    • Industrial strains (like ZU-E8 ) vs. laboratory strains

    • Genetic background variations that might influence results

  • Experimental condition variations:

    • Growth conditions (temperature, media composition)

    • Stress conditions (type and concentration of inhibitors)

    • Duration of experiments

  • Expression level considerations:

    • Native expression vs. overexpression effects

    • Stability of expressed proteins

  • Protein complex context:

    • LSM6 functions as part of a complex

    • Variations in complex partners could affect results

    • Different studies might observe effects on different LSM6-containing complexes

To resolve contradictions, researchers should:

  • Directly compare strains under identical conditions

  • Use multiple complementary techniques

  • Consider that LSM6 may have multiple distinct functions

What statistical approaches are recommended for analyzing growth phenotypes in LSM6 variants?

For robust analysis of growth phenotypes in LSM6 variants, recommended statistical approaches include:

  • Experimental design considerations:

    • Sufficient biological replicates (minimum 3-5)

    • Appropriate controls (wild-type, empty vector)

    • Account for batch effects

  • Growth curve analysis:

    • Fit growth data to appropriate mathematical models

    • Extract parameters (lag phase, maximum growth rate, maximum OD)

  • Statistical methods:

    • For comparing multiple strains: ANOVA followed by post-hoc tests

    • For time-series data: Linear mixed models as described in search result

    • When accounting for genetic background: Use kinship matrix correction in a linear mixed model implemented in software like GMMAT

  • Control variables to include in statistical models:

    • Testing chamber effects (which can be significant, η²p = 0.047 ± 0.009 for cocaine and η²p = 0.037 ± 0.009 for saline in the mouse study described in )

    • Position effects (e.g., active lever position: left vs. right)

    • Age and sex of organisms

    • Testing day/batch

These approaches ensure robust statistical analysis that can properly account for the various sources of variation in biological experiments.

What techniques are most reliable for detecting LSM6-RNA interactions?

For investigating LSM6-RNA interactions, the following techniques are recommended:

  • RNA immunoprecipitation (RIP):

    • Tag LSM6 with an epitope tag

    • Immunoprecipitate under native conditions

    • Identify associated RNAs by RT-PCR or RNA-seq

    • In search result , nearly all the U6 snRNA was found to be associated with LSM3 protein in cells expressing an LSM3-ProtA fusion

  • Cross-linking and immunoprecipitation (CLIP):

    • UV cross-linking to capture direct RNA-protein interactions

    • High-throughput sequencing of associated RNAs

    • Provides higher resolution of binding sites than RIP

  • In vitro binding assays:

    • Electrophoretic mobility shift assays with purified components

    • Filter binding assays

    • Surface plasmon resonance for kinetic measurements

  • Structural studies:

    • Crystallography or cryo-EM of RNA-protein complexes

    • NMR for smaller complexes or domains

  • Mutational analysis:

    • Test the effect of mutations in RNA or protein on binding

    • Identify critical residues for interaction

These approaches complement each other and provide a comprehensive understanding of LSM6-RNA interactions both in vitro and in vivo.

What are key considerations for designing gene knockout and complementation studies for LSM6?

When designing gene knockout and complementation studies for LSM6, researchers should consider:

  • Knockout strategy:

    • Complete gene deletion via homologous recombination

    • CRISPR-Cas9 mediated disruption

    • Conditional systems if needed

  • Phenotypic analysis:

    • Growth assays at different temperatures (since LSM6 disruption shows temperature sensitivity at 37°C)

    • RNA processing efficiency

    • Stress tolerance tests

    • Complex formation assessment

  • Complementation approaches:

    • Plasmid-based vs. genomic reintegration

    • Native promoter vs. constitutive/inducible promoters

    • Expression level verification

  • Control experiments:

    • Empty vector controls

    • Complementation with LSM6 orthologs from related species

    • Verification of knockout by PCR and sequencing

Based on search result , LSM6 knockout strains show slower growth than wild-type strains, with this phenotype exacerbated at 37°C, indicating that complementation studies should include growth assessment at both standard (30°C) and elevated (37°C) temperatures.

How can LSM6 overexpression be optimized for enhancing yeast tolerance to fermentation inhibitors?

To optimize LSM6 overexpression for enhancing yeast tolerance to fermentation inhibitors, consider:

  • Expression system optimization:

    • Test different promoters (constitutive vs. inducible)

    • Optimize codon usage for high expression

    • Evaluate different copy numbers and integration sites

  • Strain background selection:

    • Start with industrial strains with desirable base characteristics (like ZU-E8 )

    • Consider genetic background compatibility

  • Process optimization:

    • Determine optimal fermentation conditions for LSM6-overexpressing strains

    • Test performance with different inhibitor combinations and concentrations

  • Combinatorial approaches:

    • Combine LSM6 overexpression with other tolerance-enhancing modifications

    • Test synergistic effects with other stress response genes

  • Performance metrics to evaluate optimization:

    ParameterOptimization TargetNotes
    Xylose utilization>90%ZU-910 achieved 90.2%
    Ethanol yieldMaximizeZU-910 achieved 26.9 g/L
    Inhibitor toleranceMultiple inhibitorsTest acetic acid, furfural, SO4(2-)
    Fermentation timeMinimize96h baseline
    Real hydrolysate performanceMaximize50% higher xylose conversion
  • Scale-up considerations:

    • Test in progressively larger fermentation systems

    • Assess genetic stability over multiple generations

The data from search result indicates significant potential, with the LSM6-overexpressing strain ZU-910 showing 8.5- to 10-fold higher ethanol production than the control strain in inhibitor-containing media.

What experimental design approaches can help identify the mechanism of LSM6-mediated inhibitor tolerance?

To elucidate the mechanism of LSM6-mediated inhibitor tolerance, consider these experimental design approaches:

  • Transcriptome analysis:

    • Compare gene expression profiles of LSM6-overexpressing vs. control strains

    • Focus on stress response pathways and detoxification mechanisms

    • Examine expression before and after inhibitor exposure

  • Metabolite profiling:

    • Analyze changes in central carbon metabolism

    • Measure inhibitor compounds and potential detoxification products

    • Track energy metabolism indicators (ATP/ADP ratio, NADH/NAD+ ratio)

  • Genetic interaction mapping:

    • Perform systematic gene deletions in LSM6-overexpressing background

    • Identify synthetic lethal or synthetic rescue interactions

    • Use this information to place LSM6 in known stress response pathways

  • Experimental design steps (following guidelines from ):

    • Step 1: Define variables (independent: LSM6 expression level; dependent: inhibitor tolerance)

    • Step 2: Control extraneous variables (strain background, growth conditions)

    • Step 3: Design treatments (vary LSM6 expression systematically, test different inhibitors)

  • Domain mutation studies:

    • Create mutations in different functional domains of LSM6

    • Test which domains are critical for inhibitor tolerance

    • Determine if RNA binding is required for the tolerance phenotype

These approaches, when properly designed with appropriate controls and statistical analysis, can provide insights into whether LSM6's effect on inhibitor tolerance is through direct detoxification, altered RNA processing of stress response genes, or other mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.